The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 13, 2016

Filed:

Mar. 22, 2011
Applicants:

Moshit Lindzen, Rehovot, IL;

Yosef Yarden, Rehovot, IL;

Inventors:

Moshit Lindzen, Rehovot, IL;

Yosef Yarden, Rehovot, IL;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); G01N 33/574 (2006.01); A61K 31/7068 (2006.01); C07K 16/22 (2006.01); G01N 33/50 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
G01N 33/57423 (2013.01); A61K 31/7068 (2013.01); A61K 39/3955 (2013.01); C07K 16/22 (2013.01); G01N 33/5011 (2013.01); G01N 33/57438 (2013.01); G01N 33/57492 (2013.01); A61K 2039/505 (2013.01); A61K 2039/507 (2013.01); C07K 2317/73 (2013.01); C07K 2317/76 (2013.01); G01N 2500/00 (2013.01);
Abstract

A method of selecting a target for treatment of a hyperproliferative disease in a subject in need thereof is disclosed. The method comprising analyzing an amount and/or activity of at least one ErbB ligand in a biological sample from the subject, wherein an ErbB ligand which shows an up-regulated amount and/or activity compared to a non-hyperproliferative cell or tissue above a predetermined level is selected as a target for treatment of the hyperproliferative disease. Methods of treating hyperproliferative diseases, monoclonal antibodies and pharmaceutical compositions are also disclosed.


Find Patent Forward Citations

Loading…